Keyword: PATH Malaria Vaccine Initiative
The two new grants will support development of universal flu and malaria vaccines leveraging CureVac’s RNActive mRNA-based platform.
PATH, Walter Reed and GSK have partnered to determine whether tweaking the regimen of Mosquirix could lead to better malaria protection.
The Radboud University Medical Center in the Netherlands, the Instituto de Medicina Molecular Lisboa in Portugal, and PATH are collaborating on a human trial of a novel malaria vaccine.
The WHO said the first-of-a-kind GlaxoSmithKline’s malaria vaccine is ready for local pilots with $15 million in new funding from a global financing group.